The Hinckley Institute of Politics recently hosted a panel that looks at the debate playing out in Utah over medical marijuana.
Earlier this year, the Utah State Legislature passed laws that will legalize medical marijuana for a very small number of people: those with a terminal illness who, at the time a doctor issues a prescription, have less than 6 months to live.
Meanwhile, an advocacy group is trying to enact a much broader medical marijuana law through a ballot initiative – to provide the drug to people suffering from an array of illnesses. That initiative now appears likely to be on your ballot this November.
In February, people from varying sides of the medical marijuana debate met at the Hinckley Institute of Politics at the University of Utah to make their case.
The panelists include: Derek Monson from the Sutherland Institute; Dr. Karen Buchi of the University of Utah Medical Marijuana/Opioid Taskforce; Dr. Karen Wilcox from University of Utah’s Dept. of Pharmacology and Toxicology; DJ Schanz, director of Utah Patients Coalition; Doug Rice, board member of the Utah Epilepsy Association; Michelle McOmber, CEO of the Utah Medical Association; and the conversation was moderated by public radio producer, Erik Neumann.
The panel was recorded on February 14th, 2018.
How do you feel about this topic?
Is there anything else you think we should know? We'd like to hear your thoughts. Send us your feedback using the form below.
